Sami Shousha

6.7k total citations
160 papers, 4.6k citations indexed

About

Sami Shousha is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Sami Shousha has authored 160 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Oncology, 46 papers in Pathology and Forensic Medicine and 44 papers in Cancer Research. Recurrent topics in Sami Shousha's work include Breast Cancer Treatment Studies (39 papers), Breast Lesions and Carcinomas (37 papers) and HER2/EGFR in Cancer Research (24 papers). Sami Shousha is often cited by papers focused on Breast Cancer Treatment Studies (39 papers), Breast Lesions and Carcinomas (37 papers) and HER2/EGFR in Cancer Research (24 papers). Sami Shousha collaborates with scholars based in United Kingdom, United States and Kuwait. Sami Shousha's co-authors include R. Charles Coombes, David Peston, Eric O. Aboagye, Laura Kenny, Adil Al‐Nahhas, David M. Vigushin, Simak Ali, H D Sinnett, R A Parkins and Jie Jiang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Communications.

In The Last Decade

Sami Shousha

159 papers receiving 4.5k citations

Peers

Countries citing papers authored by Sami Shousha

Since Specialization

Citations

This map shows the geographic impact of Sami Shousha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sami Shousha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sami Shousha more than expected).

Fields of papers citing papers by Sami Shousha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sami Shousha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sami Shousha. The network helps show where Sami Shousha may publish in the future.

Co-authorship network of co-authors of Sami Shousha

This figure shows the co-authorship network connecting the top 25 collaborators of Sami Shousha. A scholar is included among the top collaborators of Sami Shousha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sami Shousha. Sami Shousha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oncogenic EP300 can be targeted with inhibitors of aldo-keto reductases 2019 ·Biochemical Pharmacology ·Zimam Mahmud, Muhammad Asaduzzaman, (unknown), Nahal Masrour, (unknown), R. Charles Coombes, Sami Shousha, Yunhui Hu, Eric W.‐F. Lam, Ernesto Yagüe	8
2	All Benign and Malignant Apocrine Breast Lesions Over-Express Claudin 1 and 3 and Are Negative for Claudin 4 2019 ·Pathology & Oncology Research ·Sami Shousha, (unknown), (unknown)	1
3	CD10-positive myoepithelial cells are usually prominent around in situ lobular neoplasia of the breast and much less prominent or absent in DCIS 2016 ·Journal of Clinical Pathology ·Sami Shousha, (unknown), (unknown), (unknown)	4
4	Epidermal growth factor receptor status in early stage breast cancer is associated with cellular proliferation but not cross-talk 2011 ·Journal of Clinical Pathology ·Justin Stebbing, (unknown), (unknown), Rachel Payne, Jonathan Krell, Richard Szydlo, David Peston, Jacqueline S. Lewis, R. Charles Coombes, Sami Shousha	5
5	Reproducibility of [11C]Choline-Positron Emission Tomography and Effect of Trastuzumab 2010 ·Clinical Cancer Research ·Laura Kenny, Kaiyumars Contractor, Rainer Hinz, Justin Stebbing, Carlo Palmieri, Jie Jiang, Sami Shousha, Adil Al‐Nahhas, R. Charles Coombes, Eric O. Aboagye	42
6	Altered Tissue 3′-Deoxy-3′-[18F]Fluorothymidine Pharmacokinetics in Human Breast Cancer following Capecitabine Treatment Detected by Positron Emission Tomography 2009 ·Clinical Cancer Research ·Laura Kenny, Kaiyumars Contractor, Justin Stebbing, Adil Al‐Nahhas, Carlo Palmieri, Sami Shousha, R. Charles Coombes, Eric O. Aboagye	49
7	Evaluation of automated silver‐enhanced in situ hybridization (SISH) for detection of HER2 gene amplification in breast carcinoma excision and core biopsy specimens 2009 ·Histopathology ·Sami Shousha, David Peston, B.K. Amo-Takyi, Matthew A. Morgan, Bharat Jasani	38
8	Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography 2007 ·European Journal of Nuclear Medicine and Molecular Imaging ·Laura Kenny, R. Charles Coombes, David M. Vigushin, Adil Al‐Nahhas, Sami Shousha, Eric O. Aboagye	208
9	Metastatic ductal eccrine adenocarcinoma masquerading as an invasive ductal carcinoma of the male breast 2007 ·Journal of Cutaneous Pathology ·(unknown), Sami Shousha, (unknown), Adrian Lim, (unknown), (unknown), Cathryn Brock, Carlo Palmieri	6
10	Preoperative gefitinib versus gefitinib and anastrozole in postmenopausal patients with oestrogen-receptor positive and epidermal-growth-factor-receptor-positive primary breast cancer: a double-blind placebo-controlled phase II randomised trial 2005 ·The Lancet Oncology ·Andreas Polychronis, H D Sinnett, Dimitri Hadjiminas, Hemant Singhal, Janine Mansi, (unknown), Sami Shousha, Jie Jiang, David Peston, Nigel Barrett, David M. Vigushin, (unknown), (unknown), Simak Ali, Martin J. Slade, R. Charles Coombes	160
11	Inhibiting estrogen responses in breast cancer cells using a fusion protein encoding estrogen receptor-α and the transcriptional repressor PLZF 2005 ·Gene Therapy ·Laki Buluwela, Joanna Pike, Danish Mazhar, Tahereh Kamalati, Stephen M. Hart, Rajai Al-Jehani, (unknown), Naina Patel, (unknown), Dean A. Heathcote, (unknown), Fladia Phoenix, Richard Hill, Eric O. Aboagye, Sami Shousha, Jonathan Waxman, Nicholas R. Lemoine, Arthur Zelent, R. Charles Coombes, Simak Ali	13
12	Myoepithelial markers are expressed in at least 29% of oestrogen receptor negative invasive breast carcinoma 2004 ·Modern Pathology ·Rachel Kesse‐Adu, Sami Shousha	47
13	Morphologic Spectrum of Estrogen Receptor–Negative Breast Carcinoma 2002 ·Archives of Pathology & Laboratory Medicine ·Richard L. Scawn, Sami Shousha	23
14	The location of acidic fibroblast growth factor in the breast is dependent on the activity of proteases present in breast cancer tissue 1997 ·British Journal of Cancer ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sami Shousha, Caroline L. Johnston, R. Charles Coombes, Jennifer J. Gomm	16
15	Fibroblast growth factor 2 in breast cancer: occurrence and prognostic significance 1997 ·British Journal of Cancer ·(unknown), (unknown), RC Coope, Matthew Law, (unknown), Sami Shousha, R. Charles Coombes, (unknown)	71
16	Differential expression of gp200-MR6 molecule in benign hyperplasia and down-regulation in invasive carcinoma of the breast 1996 ·British Journal of Cancer ·(unknown), (unknown), Sami Shousha, (unknown), M. A. Ritter	16
17	Oesophageal and gastric carcinoma in the Republic of Yemen 1995 ·British Journal of Cancer ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sami Shousha, (unknown)	68
18	Glandular inclusions in fetal myocardium 1994 ·Histopathology ·N. Aqel, Sami Shousha	1
19	C‐erbB‐2 oncoprotein in screen‐detected breast carcinoma: An immunohistological study 1993 ·International Journal of Cancer ·(unknown), Peter C. Taylor, H. Michael Shepard, M Feldmann, H D Sinnett, Sami Shousha	3
20	Recurrent bleeding from idiopathic ulceration of small bowel. 1984 ·BMJ ·Michael Glynn, (unknown), Sami Shousha, R A Parkins	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact